Application Notes

Tuesday, October 01, 2019
An Interview with… Anthony Qu, PhD, Cambrex
In drug product manufacturing, it is critically important to adequately treat each patient based on their individual needs. Read More
Tuesday, October 01, 2019
An Interview with… Anthony Qu, PhD, Cambrex
In drug product manufacturing, it is critically important to adequately treat each patient based on their individual needs. Read More
Tuesday, October 01, 2019
AstraZeneca selects N-SIDE Suite for Clinical Trials
N-SIDE announced AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Read More
Monday, September 30, 2019
ASLAN, Bukwang Establish a Joint Venture, JAGUAHR Therapeutics
ASLAN and Bukwang announced they have established a new joint venture to develop preclinical aryl hydrocarbon receptor (AhR) antagonists from ASLAN’s early stage pipeline. Read More
Monday, September 30, 2019
Oracle Health Sciences, MMS Collaborate to Deliver Database for Oncology Sponsor
MMS Holdings has collaborated with Oracle Health Sciences and a specialized Oncology pharmaceutical company. Read More
Monday, September 30, 2019
Teneobio Licenses Oncology Multispecific Product to Janssen
Teneobio announced one of the Janssen Companies has elected to exercise a commercial option to license and advance an undisclosed multispecific product for development in an oncology indication. Read More
Monday, September 30, 2019
Have you considered the impact of your decisions while developing upstream?
Advance your molecule from the laboratory to the clinic without sacrificing product quality, process efficiency, or patient safety.
Navigate complexities associated with business planning,

Monday, September 30, 2019

FDA Announces New Sentinel System Contract

The FDA is announcing an award granting a new five-year contract for the Sentinel System, the FDA’s flagship active surveillance system. Read More

Monday, September 30, 2019

Horizon Discovery Signs License Agreement with Glenmark

Horizon Discovery Group announced the full commercial licensing to Glenmark of its gene-edited Glutamine Synthetase knockout Chinese Hamster Ovary K1 cell line. Read More

Monday, September 30, 2019

Fate Therapeutics Announces Opening of cGMP Manufacturing Facility

Fate Therapeutics has opened its cGMP compliant manufacturing facility for the clinical production of its off-the-shelf natural killer cell and chimeric antigen receptor (CAR) T-cell product ... Read More

Friday, September 27, 2019

GSK Completes $120M Manufacturing Expansion

GlaxoSmithKline (GSK) has completed a $120 million expansion of its manufacturing site in the Philadelphia suburb of Upper Merion, PA. Read More

Friday, September 27, 2019

Translate Bio Announces Manufacturing Agreement with AMRI

Translate Bio has entered into a multi-year strategic manufacturing agreement with AMRI in support of the planned expansion of Translate Bio’s cGMP clinical mRNA manufacturing capabilities. Read More

Thursday, September 26, 2019

New Technology Delivery Model Provides CROs Flexibility, Control, and Revenue

Electronic data capture (EDC) solutions have been used to collect important information in clinical research for more than 20 years. Today the technology is widely used across the pharmaceutical ... Read More

Thursday, September 26, 2019

GENEWIZ Opens European Headquarters in Germany

GENEWIZ announced the opening of its European headquarters for its genomics business in Leipzig, Germany. Read More

Thursday, September 26, 2019

Torrent Expands Losartan Potassium Recall

Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level. Read More

An Interview with… Anthony Qu, PhD, Cambrex

An Interview with… Anthony Qu, PhD, Cambrex

AstraZeneca selects N-SIDE Suite for Clinical Trials

ASLAN, Bukwang Establish a Joint Venture, JAGUAHR Therapeutics

Oracle Health Sciences, MMS Collaborate to Deliver Database for Oncology Sponsor

Teneobio Licenses Oncology Multispecific Product to Janssen

Have you considered the impact of your decisions while developing upstream?

FDA Announces New Sentinel System Contract

Horizon Discovery Signs License Agreement with Glenmark

Fate Therapeutics Announces Opening of cGMP Manufacturing Facility

GSK Completes $120M Manufacturing Expansion

Translate Bio Announces Manufacturing Agreement with AMRI

New Technology Delivery Model Provides CROs Flexibility, Control, and Revenue

GENEWIZ Opens European Headquarters in Germany

Torrent Expands Losartan Potassium Recall

Current Issue

April/May/June 2026

2026 Company Focus & Industry Reference Guide

2026 Company Focus & Industry Reference Guide

Subscriptions

Connect with Us

Sign Up for Our Newsletter